logo-loader

Pharmaxis begins exporting its cystic fibrosis drug Bronchitol® to the USA

Published: 13:25 09 Feb 2021 AEDT

Pharmaxis Ltd's (ASX:PXS) (OTCMKTS:PXSLY) (FRA:UUD) Gary Phillips speaks to Proactive's Andrew Scott following the news it has exported the first shipment of its locally developed and manufactured drug Bronchitol® to the USA. Phillips describes it as a proud and very rare achievement for a home‐ grown pharmaceutical research company.

Syntara to start Phase 2 study targeting MDS

Syntara Ltd (ASX:SNT) CEO Gary Phillips joins Proactive’s Jonathan Jackson to share insights on the company's expansion of its lead drug, SNT-5505, into new medical indications, including a promising Phase 2 study targeting myelodysplastic syndrome (MDS). Phillips highlighted the significance of...

on 14/2/24